Not medical advice
Everything on RetaRadar, including rankings, prices, news and the dosing calculator, is for general information and research purposes. It is not medical advice and is no substitute for a consultation with a doctor or pharmacist.
Regulatory status of retatrutide
Retatrutide is an investigational medicine in clinical development by Eli Lilly. It has no marketing authorisation from the MHRA, EMA or FDA. Products sold by the suppliers listed here are sold as research chemicals and are labelled as not for human consumption. Supplying an unlicensed medicine for human use is restricted under the Human Medicines Regulations 2012. You are responsible for complying with the law where you live.
Accuracy
Prices, stock and supplier details change frequently. We check them regularly but can’t guarantee they are current. Always confirm details with the supplier. Calculator results are arithmetic only. Double-check every calculation yourself.
Side effects and reporting
If you suspect a side effect from any medicine or a fake medicine, report it through the MHRAYellow Card scheme and contact NHS 111 or your GP.